GSK acquires Bristol-Myers HIV portfolio for $350M up front
February 22, 2016 at 12:36 PM EST
GlaxoSmithKline (NYSE: GSK) acquired the HIV portfolio from Bristol-Myers Squibb (NYSE: BMY). Both sides announced the preliminary deal in December...
